A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

IsraelRecruitingPHASE1, PHASE2

Conditions

Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope, Duarte, California, United States

  • City of Hope - Orange County Lennar Foundation Cancer Center, Irvine, California, United States

  • University of California, San Francisco (UCSF), San Francisco, California, United States

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Santa Monica, California, United States

  • Stanford Cancer Institute (SCI), Stanford, California, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

  • Regional Cancer Care Associates LLC (RCCA) - Freehold Location, Freehold, New Jersey, United States

  • Regional Cancer Care Associates LLC ? Howell Division, Howell Township, New Jersey, United States

  • Levine Cancer Institute, Charlotte, North Carolina, United States

  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

  • University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States

  • West Cancer Center, Germantown, Tennessee, United States

  • Flinders Medical Centre, Bedford Park, South Australia, Australia

  • Peninsula Health-Frankston Hospital, Frankston, Victoria, Australia

  • Peter Maccallum Cancer Centre, Melbourne, Victoria, Australia

  • Linear Clinical Research Limited, Nedlands, Western Australia, Australia

  • Shaare Zedek Medical Center, Jerusalem, Jerusalem, Israel

  • Rambam Medical Center, Haifa, Israel

  • Hadassah Ein Karem Hospital, Jerusalem, Israel

  • Rabin MC, Petah Tikva, Israel

  • The Chaim Sheba Medical Center, Ramat Gan, Israel

  • Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Assuta Medical Centers, Tel Aviv, Israel

  • National Cancer Center, Goyang-si, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • Asan Medical Center, Seoul, South Korea

  • Severance Hospital, Seoul, South Korea

  • Hospital Universitario Vall d Hebron, Barcelona, Spain

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

  • Centro Integral Oncológico Clara Campal Ensayos Clínicos START, Madrid, Spain

  • Hospital Clinico Universitario de Valencia, Valencia, Spain

Study leads
  • Clinical Trials

    Study Director

    Hoffmann-La Roche